INTELLIA THERAPEUTICS INC's ticker is NTLA and the CUSIP is 45826J105. A total of 245 filers reported holding INTELLIA THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 4.51 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $551,547 | -22.2% | 17,443 | +0.3% | 0.00% | 0.0% |
| Q2 2023 | $709,328 | +16.9% | 17,394 | +6.8% | 0.00% | 0.0% |
| Q1 2023 | $606,867 | -7.2% | 16,283 | -13.1% | 0.00% | 0.0% |
| Q4 2022 | $653,664 | -26.6% | 18,735 | +17.7% | 0.00% | -33.3% |
| Q3 2022 | $890,000 | +10.7% | 15,916 | +2.5% | 0.00% | 0.0% |
| Q2 2022 | $804,000 | -50.6% | 15,525 | -30.7% | 0.00% | 0.0% |
| Q1 2022 | $1,628,000 | -49.8% | 22,400 | -18.4% | 0.00% | -50.0% |
| Q4 2021 | $3,245,000 | -7.5% | 27,452 | +5.0% | 0.01% | -40.0% |
| Q3 2021 | $3,508,000 | -24.8% | 26,150 | -9.3% | 0.01% | -28.6% |
| Q2 2021 | $4,666,000 | +142.3% | 28,820 | +20.1% | 0.01% | +133.3% |
| Q1 2021 | $1,926,000 | +75.1% | 24,000 | +18.7% | 0.01% | +50.0% |
| Q4 2020 | $1,100,000 | +254.8% | 20,220 | +29.6% | 0.00% | +300.0% |
| Q3 2020 | $310,000 | +4.0% | 15,599 | +10.1% | 0.00% | -50.0% |
| Q2 2020 | $298,000 | +28.4% | 14,167 | -10.4% | 0.00% | +100.0% |
| Q4 2019 | $232,000 | -1.3% | 15,812 | -10.3% | 0.00% | 0.0% |
| Q3 2019 | $235,000 | -14.9% | 17,634 | +4.6% | 0.00% | -50.0% |
| Q2 2019 | $276,000 | -14.8% | 16,855 | -11.2% | 0.00% | 0.0% |
| Q1 2019 | $324,000 | +30.1% | 18,976 | +4.2% | 0.00% | 0.0% |
| Q4 2018 | $249,000 | -59.8% | 18,211 | -16.0% | 0.00% | -50.0% |
| Q3 2018 | $620,000 | +0.8% | 21,679 | -3.6% | 0.00% | 0.0% |
| Q2 2018 | $615,000 | +34.3% | 22,483 | +3.6% | 0.00% | +33.3% |
| Q1 2018 | $458,000 | -5.8% | 21,704 | -14.2% | 0.00% | 0.0% |
| Q4 2017 | $486,000 | -8.3% | 25,284 | +18.6% | 0.00% | -40.0% |
| Q3 2017 | $530,000 | +67.7% | 21,315 | +7.9% | 0.01% | +66.7% |
| Q2 2017 | $316,000 | +12.1% | 19,746 | -1.3% | 0.00% | 0.0% |
| Q1 2017 | $282,000 | -13.5% | 20,016 | -19.6% | 0.00% | -25.0% |
| Q4 2016 | $326,000 | – | 24,902 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Discovery Value Fund | 561,561 | $17,756,559 | 9.73% |
| MPM BioImpact LLC | 544,639 | $17,221,485 | 4.60% |
| Casdin Capital, LLC | 1,178,075 | $37,250,732 | 4.12% |
| HIMENSION CAPITAL (SINGAPORE) PTE. LTD. | 1,145,091 | $36,207,777 | 3.72% |
| Atlas Venture Associates IX, LLC | 10,000 | $316,200 | 2.69% |
| Deep Track Capital, LP | 2,000,000 | $63,240,000 | 2.44% |
| ARK Investment Management | 9,948,629 | $314,575,638 | 2.41% |
| Merlin Capital, Inc | 18,526 | $585,792 | 2.19% |
| Orchard Capital Management, LLC | 159,155 | $5,032,481 | 1.86% |
| TANG CAPITAL MANAGEMENT LLC | 397,600 | $12,572,112 | 1.77% |